← All peptides

Tesofensine

Triple monoamine reuptake inhibitor. Metabolic research.

Route
ORAL
Typical dose range
500 mcg to 1 mg
Frequency
daily
Half-life
9.16667 days
Cycle on / off (days)
56 / 28
Evidence grade
B

What Tesofensine is

Tesofensine is triple monoamine reuptake inhibitor. metabolic research. It sits within metabolic research (appetite, glycemic control, body composition). Pepture keeps Tesofensine in the library as a tracking target only, the app records what you enter but makes no recommendation about whether the compound is appropriate for you. That decision belongs with a licensed clinician.

Published pharmacokinetic data places the half-life of Tesofensine at roughly 9.16667 days, and doses recorded in the community cluster around the 500 mcg to 1 mg range. Individual protocols vary widely. Jurisdictional status (FDA-approved, prescription, or research only) depends on the specific formulation and country.

How people track Tesofensine

In Pepture, Tesofensine is typically logged alongside fasted weight, waist, appetite score, fasting glucose, so cycle impact can be reviewed at the end of a block rather than by memory. The app captures dose, site, reconstitution ratio, cycle day, and any subjective rating you choose to add.

If you are considering Tesofensine but have not started, or if you have started and want a second opinion, speak with a licensed clinician before changing any dose or cycle pattern.

Reconstitution math

Open the pre-filled Tesofensine reconstitution calculator to compute syringe units per dose.

Reported Side Effects of Tesofensine

Effects below are summarised from peer-reviewed literature or regulatory labeling where it exists. Not medical advice. Individual responses vary.

  • Transient GI effects (nausea, loose stools) PubMed
  • Injection-site reactions PubMed
  • Changes in fasting glucose in sensitive users PubMed

Compare Tesofensine

How Tesofensine stacks up against the peers most users consider.